Ocular Surgery News

06/07/2026

The Clinical Trials at the Summit meeting is getting closer. 👀

Founder and Co-Chair Dr. Arshad Khanani spoke with Healio
about what attendees can expect from this year's action-packed agenda.

The meeting will begin on Friday, 6/12, in Las Vegas!

https://vist.ly/56vmh

06/06/2026

When the community comes together, it can:

⭐Influence policy makers.
⭐Preserve patient access to -restoring care.
⭐Protect the standard of care.

Dr. Vance Thompson outlines the blueprint for in : 🔗

For more than 30 years, I have had the privilege of helping patients regain visual clarity, independence and confidence through cataract surgery. It is one of the safest and most transformative procedures in all of medicine. And yet, every year, the environment surrounding Medicare reimbursement gro...

06/05/2026

‼️BREAKING ‼️

The approved Ranluspec, an interchangeable biosimilar referencing .

The VEGF inhibitor will be available for a variety of -threatening retinal diseases.

Read more on Healio:

https://vist.ly/56rwk

Lupin

The FDA approved Ranluspec, an interchangeable biosimilar referencing Lucentis, as a treatment for vision-threatening retinal diseases, according to a press release from Lupin.

06/05/2026

Healio AI is officially partnering with The Holland Foundation for Restoration!

The partnership will integrate HFSR educational content and fundamentals, including the "Cincinnati Protocol," into Healio ’s core knowledge base.

Read more: 🔗

Healio AI partners with The Holland Foundation for Sight Restoration to Expand Trusted Clinical AI June 5, 2026 Thorofare, NJ – Healio AI is officially partnering with The Holland Foundation for Sight Restoration (HFSR) by integrating HFSR educational content and fundamentals of The Cincinnati Pro...

06/05/2026

are the unsung heroes of the OR.

In his latest blog, Dr. John Hovanesian celebrates the great work of all the engineers who develop the devices that save patient lives, and , every day.

Read more on Healio: 🔗

Engineering is a “disease” that runs in my family. My dad chaired the mechanical engineering department at Oakland University in the Detroit area. My son is graduating college as a mechanical engineer. My daughter will do the same next year in aerospace engineering, and my youngest son t...

06/04/2026

Did you catch Healio | OSN's latest Exclusive Feature? 👀

EyeSustain is bringing companies together to focus on making more .

Founder Dr. David F. Chang and industry leaders share how they are working together to reduce waste.

Before EyeSustain, sustainability efforts in ophthalmology were fragmented and isolated.That is what David F. Chang, MD, told Healio | OSN in the weeks following the organization’s founding in 2022. Now in its fourth year, EyeSustain has grown from its three initial sponsors — the Americ...

06/04/2026

Every surgeon will face secondary IOL implantation.

In this edition of CEDARS/ASPENS Debates, Dr. Brandon D. Ayres and Dr. Mitchell P. Weikert discuss possible challenges, while sharing surgical options and useful pearls.

Full article: 🔗

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.This month’s topic is secondary IOL implantation, an eventuality that sooner or later all catar...

06/04/2026

📊 Real-world data meets clinical insight!

Discover new ways to improve outcomes: https://bit.ly/3LtwnaJ

06/03/2026

‼️BREAKING‼️

Outlook Therapeutics resubmitted a biologics license application to the FDA for ONS-5010, also known as , for neovascular AMD.

Dr. Christina Y. Weng shares her expert perspective on Healio: 🔗

https://vist.ly/56hwd

06/03/2026

3 green tiles! Are you finishing it? 👀 There’s only one way to find out.

Play today’s WORD DOC and prove it: https://vist.ly/56h3f